The multi-site trial at UW–Madison is in its first phase and is testing a personalized topical medication in the form of a gel as a way to treat vascular anomalies.
Read the full article at: https://news.wisc.edu/clinical-trial-repurposes-cancer-drug-for-treatment-of-vascular-malformations/